Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings in Brief: ChemTrak

This article was originally published in The Gray Sheet

Executive Summary

ChemTrak: Diagnostics firm raises $1.3 mil. in a private placement of redeemable preferred stock with seven private investors. The placement is the first of two financing rounds anticipated by the firm. A second round of up to $2.7 mil. is expected in April. Proceeds will go towards marketing and advertising costs associated with the ongoing roll out of the firm's Parent's Alert home drug testing service. Launched in October, a "full national advertising" campaign is set to begin in April, ChemTrak reports...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009576

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel